| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/31/2003 | WO2004000328A1 Biosynthesis of hif |
| 12/31/2003 | WO2004000313A2 Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds |
| 12/31/2003 | WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 12/31/2003 | WO2004000284A1 Pharmaceutical compositions with improved dissolution |
| 12/31/2003 | WO2004000228A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 12/31/2003 | WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy |
| 12/31/2003 | WO2004000096A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 12/31/2003 | WO2004000094A2 Predictive markers in cancer therapy |
| 12/31/2003 | WO2004000009A2 Methods for selection for efficient animal growth |
| 12/31/2003 | WO2004000003A2 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process |
| 12/31/2003 | WO2003087830A3 Timp-1 as a postoperative marker for recurrent cancer |
| 12/31/2003 | WO2003087817A3 Device and method for measuring coagulation time and platelet activity |
| 12/31/2003 | WO2003087774A3 Ecist microarrays for dual screening of dna hypermethylation and gene silencing |
| 12/31/2003 | WO2003083487A3 Method of screening of compounds inducing a prolonged qt intervalon the electrocardiogram |
| 12/31/2003 | WO2003081244A3 Method of electrochemical cell analysis |
| 12/31/2003 | WO2003080869A3 Storing and detecting nucleic acid administered to a solid carrier |
| 12/31/2003 | WO2003078974A3 Improved method for on-line monitoring of lubricating oil using light in the visible and near ir spectra |
| 12/31/2003 | WO2003078582A3 Integrated system for high throughput capture of genetic diversity |
| 12/31/2003 | WO2003076658A3 A susceptibility gene for late-onset idiopathic parkinson's disease |
| 12/31/2003 | WO2003076476A3 Magnetically detectable latex articles |
| 12/31/2003 | WO2003075839A3 Methods of inducing terminal differentiation |
| 12/31/2003 | WO2003075129A3 Methods, systems, and software for identifying functional bio-molecules |
| 12/31/2003 | WO2003070876A3 Method for attaching nucleic acid molecules to electrically conductive surfaces |
| 12/31/2003 | WO2003069421A3 Methods and algorithms for cell enumeration in a low-cost cytometer |
| 12/31/2003 | WO2003069309A3 Immunocapture and functional assay for mitochondrial complex i |
| 12/31/2003 | WO2003068981A3 Method for reducing background contamination after marking reactions |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 12/31/2003 | WO2003064995A3 A guided mode resonant filter biosensor using a linear grating surface structure |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003062789A3 Methods for isolating and characterizing short-lived proteins and arrays derived therefrom |
| 12/31/2003 | WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
| 12/31/2003 | WO2003061453A3 Device and method for the identification of analytes in bodily fluids |
| 12/31/2003 | WO2003057719A3 Methods of modulating localization and physiological function of ip3 receptors |
| 12/31/2003 | WO2003056034A3 Method for the in vitro selection of binders |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003052138A3 Methods of detecting modification of genetic material |
| 12/31/2003 | WO2003048191A3 Process for the selective alkylation of -sh groups in proteins and peptides for the study of complex protein mixtures |
| 12/31/2003 | WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 12/31/2003 | WO2003046507A3 Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits |
| 12/31/2003 | WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 12/31/2003 | WO2003040685A3 Diagnosis demyelinating or spongiform disease |
| 12/31/2003 | WO2003039349A3 Method of using physiological markers to estimate cardiovascular risk |
| 12/31/2003 | WO2003038440A3 Chemokine binding molecules |
| 12/31/2003 | WO2003038399A3 Chemiluminescent acridinium compounds and their use in an assay to detect analytes |
| 12/31/2003 | WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer |
| 12/31/2003 | WO2003029814A3 Neuropilin/vegf c/vegfr 3 materials and methods |
| 12/31/2003 | WO2003027122A3 Lanthanide binding tags |
| 12/31/2003 | WO2003023353A3 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection |
| 12/31/2003 | WO2003023035A3 Glucosyltransferases which glucosylate abscisic acid |
| 12/31/2003 | WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003016566A3 Improvements relating to capillary gel array analysis |
| 12/31/2003 | WO2003001985A3 Method for detection of melanoma |
| 12/31/2003 | WO2002097059B1 Chromosome-based platforms |
| 12/31/2003 | WO2002087769A3 Method for parallel synthesis and transfer of molecules to a substrate |
| 12/31/2003 | WO2002079767A8 Method and apparatus for determination of gastrointestinal intolerance |
| 12/31/2003 | WO2002077648A3 Pathogenic and commensal vaccine antigens |
| 12/31/2003 | WO2002071070A3 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002066984A3 Arrays for determining binding of biomolecules |
| 12/31/2003 | WO2002066955A8 Method for screening compounds |
| 12/31/2003 | WO2002057989A3 Method for metabolic profiling |
| 12/31/2003 | WO2002054081A3 Proteins, genes and their use for diagnosis and treatment of kidney response |
| 12/31/2003 | WO2002044714A8 System and method for integrated analysis of data for characterizing carbohydrate polymers |
| 12/31/2003 | WO2002043578A3 Determination of risk and treatment of complications of prematurity |
| 12/31/2003 | WO2002042779A3 Axonal response to chemotropic gradients |
| 12/31/2003 | WO2002042775A3 Clinically intelligent diagnostic devices and methods |
| 12/31/2003 | WO2002042444A3 Fungal gene cluster associated with pathogenesis |
| 12/31/2003 | WO2002040962A3 Methods and reagents to reduce backgrounds of heterogeneous assays |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2002038143A3 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation |
| 12/31/2003 | WO2002036820A8 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 12/31/2003 | WO2002031198A3 Cancer-linked genes as targets for chemotherapy |
| 12/31/2003 | WO2002023199A8 Method, system, apparatus and device for discovering and preparing chemical compounds |
| 12/31/2003 | WO2002018635A8 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 12/31/2003 | WO2001088197A3 Methods and compositions for interaction trap assays |
| 12/31/2003 | WO2001082216A8 Multi-neural net imaging apparatus and method |
| 12/31/2003 | CN2596361Y Peptide nucleic acid detection chip for hepatitis B virus mutational site |
| 12/31/2003 | CN2596360Y Flowing biological chip |
| 12/31/2003 | CN2596359Y Integrated device for preparing biological molecular chip and instant detection |
| 12/31/2003 | CN2596354Y Soft package molk quality detector |
| 12/31/2003 | CN2596348Y Laser fresh molk fat protein content detector |
| 12/31/2003 | CN1464977A Biosensor and method for analyzing blood components using it |
| 12/31/2003 | CN1464909A Cell diagnosing method, and device and apparatus used for it |
| 12/31/2003 | CN1464309A Usage of alpha-mannosidase in the immunocyte subgroup sectionalization and method thereof |
| 12/31/2003 | CN1464308A A polypeptide chip agent box and uses thereof |
| 12/31/2003 | CN1464307A Embedded high-pass three-dimensional biological detecting technique and agent box |
| 12/31/2003 | CN1464306A Human leulocyte antigens genotyping chip, method for preparing the same and method for detecting human leukocyte antigens |
| 12/31/2003 | CN1464305A Novel process for determining herb character |
| 12/31/2003 | CN1464304A Probe board containing enclosed type reactor and use thereof |
| 12/31/2003 | CN1464303A Process for preparing high polymer micro-flow control chips |
| 12/31/2003 | CN1464300A Apparatus for continuous and automatic measurement of radial flow sediment content |
| 12/31/2003 | CN1464066A Alpha-fucosidase monostable liquid detecting reagent |
| 12/31/2003 | CN1464064A Process for preparing telomeric repeat binding factor (TRF1) monoclonal antibodies and use thereof |
| 12/31/2003 | CN1464059A Actinine fluorescent protein novel gene and its cloning, expression and use |
| 12/31/2003 | CN1464001A Chloro-silicane polyethylene derivative, process for synthesizing and use thereof |
| 12/31/2003 | CN1464000A Chloro-silicane polyethylene derivative, process for synthesizing and use thereof |
| 12/31/2003 | CN1463985A Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom |
| 12/31/2003 | CN1133077C Method for diagnosing autoimmune diseases |